Stephen P. Ethier Ph.D. is the developer of the SUM series of human breast cancer cell lines. Dr. Ethier is Professor of Pathology and Laboratory Medicine at the Medical University of South Carolina, in Charleston, South Carolina. Before joining MUSC in January of 2012, Dr. Ethier was the Associate Director for Basic Research and Deputy Director of the Barbara Ann Karmanos Cancer Institute (an NCI-designated Comprehensive Cancer Center), and Professor of Oncology at Wayne State University in Detroit, Michigan. Dr. Ethier developed the SUM series of breast cancer cell lines while on the faculty of the University of Michigan Medical School. He joined the University of Michigan faculty in 1986 and over 17 years rose through the ranks to become Professor in the Department of Radiation Oncology and was named the Ruth Tuttle-Freeman Research Professor of Radiation Oncology in 2002. While at the University of Michigan, Dr Ethier was the co-leader, along with Dr. Max Wicha, of the Breast Oncology Program of the University of Michigan Comprehensive Cancer Center. Dr. Ethier has spent his entire career studying the biology of breast cancer. In recent years, his work has been focused on the genomic alterations that drive breast cancer development, and how those genomic changes result in altered patterns of cell signaling that lead to the expression of malignant phenotypes in breast cancer cells.
A complete list of Dr. Ethier’s publications can be found here:
Recently, Dr. Ethier published his first novel, “The Lewis Exchange“. Find it on Amazon!
More recently, Dr. Ethier published a book titled: Using Functional Genomics and Artificial Intelligence to Reverse Engineer Human Cancer Cells. The book was published by Cambridge Scholars Publishing.
Back to SLKBase Home
You must be logged in to post a comment.